A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Seattle, WA · Vancouver, WA · +93 more sites
12 recruiting crohn's disease studies with a site in Seattle, WA.
Sponsor: Hoffmann-La Roche
Seattle, WA · Vancouver, WA · +93 more sites
Sponsor: Merck Sharp & Dohme LLC
Bellevue, WA · Seattle, WA · +84 more sites
Sponsor: Eli Lilly and Company
Seattle, WA · +14 more sites
Sponsor: Takeda
Seattle, WA · +29 more sites
Sponsor: AbbVie
Seattle, WA · Tacoma, WA · +62 more sites
Sponsor: Seattle Children's Hospital
Seattle, WA
Sponsor: Connecticut Children's Medical Center
Seattle, WA · +21 more sites
Sponsor: Takeda
Seattle, WA · +16 more sites
Sponsor: Weill Medical College of Cornell University
Seattle, WA · +5 more sites
Sponsor: Abivax S.A.
Seattle, WA · +42 more sites
Sponsor: Seattle Children's Hospital
Seattle, WA
Sponsor: Seattle Children's Hospital
Seattle, WA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.